Record-Breaking Autism Rates Reported With New CDC Criteria Dec. 2, 2021 Childhood autism rates are at the highest level since the CDC began tracking the disorder in 2000. The increase likely reflects improvements in diagnosis and identification, not an increase in incidence. Sydney Pettygrove, PhD, associate research professor and epidemiologist at the Mel and Enid Zuckerman College of Public Health, and a principal investigator for the Autism and Developmental Disabilities Monitoring site in Arizona, is quoted. Medscape
The Role of Travel Restrictions Amid Omicron Dec. 2, 2021 Now that the COVID variant Omicron is confirmed in the U.S., questions are arising around the role of the travel ban. This as new details are emerging about a new travel requirement government leaders are now considering. Joe Gerald, MD, PhD, associate professor and director of the public health policy and management program at the Mel and Enid Zuckerman College of Public Health, says to make the travel restrictions more effective he thinks we should also be doing testing, quarantining and isolation. KOLD-TV (Tucson, AZ)
HIV/AIDS Care Team, Training Program Pivot During Pandemic Dec. 1, 2021 Pandemic-related changes helped provide a continuum of care, while also reducing clinic “no-shows.” Read more Image
COVID-19 Antiviral Drugs Dec. 1, 2021 Jun Wang, PhD, associate professor of pharmacology and toxicology at the R. Ken Coit College of Pharmacy, explains how the new antiviral pills from Merck and Pfizer fit into the framework of existing COVID-19 therapies. SciLine
Biden Outlines New Steps to Combat COVID-19 Through Winter Months Dec. 1, 2021 President Joe Biden's multi-pronged approach puts a heavy emphasis on expanding vaccinations to Americans who have resisted getting shots and to provide boosters to all adults. "We need more at-home testing,” said Shad Marvasti, MD, associate professor and director of the public health, prevention. population health curriculum at the College of Medicine – Phoenix. KTKV/KPHO (Phoenix, AZ)
Omicron Could Threaten COVID-19 Immunity — But We’re Not Going Back to ‘Square One’ Dec. 1, 2021 Immunologists and virologists say that while it will still take time to determine the variant's real-world impact, our immunity from vaccines and prior infection could take a significant hit if it takes off globally. "I wouldn't say that this one's going to put us back to zero," said Deepta Bhattacharya, PhD, a professor and immunobiologist at the College of Medicine – Tucson. "But I do think that if it does spread, it's going to be a bigger problem than any of the variants we've seen before." Canadian Broadcasting Corporation (CBC)
University of Arizona Joins Clinical Trial to Evaluate Aiberry AI Platform’s Ability to Detect Depression Dec. 1, 2021 Allison J. Huff, DHEd, assistant professor in the Department of Family and Community Medicine at the College of Medicine – Tucson, is involved in a clinical trial using artificial intelligence technology that analyzes a patient’s words, voice, and facial expressions to detect mental health conditions and integrates with telehealth services. AZoRobotics
‘Interesting and Important’ Results from AVATAR Trial Presented at AHA Dec. 1, 2021 Nancy K. Sweitzer, MD, PhD, director of the UArizona Sarver Heart Center, discusses results from the AVATAR trial presented at this year’s American Heart Association Scientific Sessions. The trial evaluated surgical aortic valve replacement among asymptomatic patients with severe aortic stenosis. Healio
University of Arizona Joins Clinical Study to Test Aiberrys AI Platform to Detect Mental Illness Nov. 30, 2021 Allison J. Huff, DHEd, assistant professor in the Department of Family and Community Medicine at the College of Medicine – Tucson, is involved in a clinical trial using artificial intelligence technology that analyzes a patient’s words, voice, and facial expressions to detect mental health conditions and integrates with telehealth services. User Walls